Recent advances in retrometabolic drug design and targeting approachesBODOR, N.Pharmazie. 2000, Vol 55, Num 3, pp 163-166, issn 0031-7144Article

Brain targeting of drugs and neuropeptides by retrometabolic design approachesBODOR, N.STP pharma sciences. 1997, Vol 7, Num 1, pp 43-52, issn 1157-1489Article

Novel approaches to the design of safer drugs: soft drugs and site-specific chemical delivery systemsBODOR, N.Advances in Drug Research. 1984, Vol 13, pp 255-331, issn 0065-2490Article

SOFT-DRUGS. V: THIAZOLIDINE-TYPE DERIVATIVES OF PROGESTERONE AND TESTOSTERONEBODOR N; SLOAN KB.1982; JOURNAL OF PHARMACEUTICAL SCIENCES; ISSN 0022-3549; USA; DA. 1982; VOL. 71; NO 5; PP. 514-520; BIBL. 15 REF.Article

Drug targeting and retrometabolic drug design approaches: introductionBODOR, N.Advanced drug delivery reviews. 1994, Vol 14, Num 2-3, pp 157-166, issn 0169-409XArticle

O-ACYLATION OF ACIDIC METHYLENE COMPOUNDSSLOAN KB; BODOR N.1976; J. ORG. CHEM.; U.S.A.; DA. 1976; VOL. 41; NO 1; PP. 165-166; BIBL. 10 REF.Article

HYDROXYMETHYL AND ACYLOXYMETHYL PRODRUGS OF THEOPHYLLINE: ENHANCED DELIVERY OF POLAR DRUGS THROUGH SKINSLOAN KB; BODOR N.1982; INTERNATIONAL JOURNAL OF PHARMACEUTICS; ISSN 0378-5173; NLD; DA. 1982; VOL. 12; NO 4; PP. 299-313; BIBL. 2 P.Article

IMPROVED DELIVERY THROUGH BIOLOGICAL MEMBRANES. IX: KINETICS AND MECHANISM OF HYDROLYSIS OF METHYLSULFINYLMETHYL 2-ACETOXYBENZOATE AND RELATED ASPIRIN PRODRUGSLOFTSSON T; BODOR N.1981; J. PHARM. SCI.; ISSN 0022-3549; USA; DA. 1981; VOL. 70; NO 7; PP. 750-755; BIBL. 15 REF.Article

Retrometabolic drug design concepts in ophthalmic target-specific drug deliveryBODOR, N.Advanced drug delivery reviews. 1995, Vol 16, Num 1, pp 21-38, issn 0169-409XArticle

IMPROVED DELIVERY THROUGH BIOLOGICAL MEMBRANES. XI: A REDOX CHEMICAL DRUG-DELIVERY SYSTEM AND ITS USE FOR BRAIN-SPECIFIC DELIVERY OF PHENYLETHYLAMINEBODOR N; FARAG HH.1983; JOURNAL OF MEDICINAL CHEMISTRY; ISSN 0022-2623; USA; DA. 1983; VOL. 26; NO 3; PP. 313-318; BIBL. 25 REF.Article

IMPROVED DELIVERY THROUGH BIOLOGICAL MEMBRANES. XII: THE EFFECT OF THE INCORPORATION OF BIPHASIC SOLUBILIZING GROUPS INTO PRODUCTS OF STEROIDSBODOR N; SLOAN KB.1983; INTERNATIONAL JOURNAL OF PHARMACEUTICS; ISSN 0378-5173; NLD; DA. 1983; VOL. 15; NO 3; PP. 235-250; BIBL. 1 P.Article

IMPROVED DELIVERY THROUGH BIOLOGICAL MEMBRANES. X: PERCUTANEOUS ABSORPTION AND METABOLISM OF METHYLSULFINYLMETHYL 2-ACETOXYBENZOATE AND RELATED ASPIRIN PRODRUGSLOFTSSON T; BODOR N.1981; J. PHARM. SCI.; ISSN 0022-3549; USA; DA. 1981; VOL. 70; NO 7; PP. 756-758; BIBL. 16 REF.Article

SOFT DRUGS. II: SOFT ALKYLATING COMPOUNDS AS POTENTIAL ANTITUMOR AGENTSBODOR N; KAMINSKI JJ.1980; J. MEDICIN. CHEM.; USA; DA. 1980; VOL. 23; NO 5; PP. 566-569; BIBL. 11 REF.Article

GROUND STATES OF MOLECULES. XX. MINDO/2 STUDY OF SOME CARBENES AND THEIR INTRAMOLECULAR REARRANGEMENTSBODOR N; DEWAR MJS.1972; J. AMER. CHEM. SOC.; U.S.A.; DA. 1972; VOL. 94; NO 26; PP. 9103-9106; BIBL. 16 REF.Serial Issue

Retrometabolic approaches for drug design and targetingBODOR, N.Pharmazie. 1997, Vol 52, Num 7, pp 491-494, issn 0031-7144Article

3-BROMO-4,4-DIMETHYL-2-OXAZOLIDINONE. PREPARATION AND INVESTIGATION OF A NEW BROMINATING AGENTKAMINSKI JJ; BODOR N.1976; TETRAHEDRON; G.B.; DA. 1976; VOL. 32; NO 10; PP. 1097-1099; BIBL. 11 REF.Article

Design of biologically safer chemicalsBODOR, N.Chemtech. 1995, Vol 25, Num 10, pp 22-32, issn 0009-2703Article

IMPROVED DELIVERY THROUGH BIOLOGICAL MEMBRANES. XV: SURTAINED BRAIN DELIVERY OF BERBERINEBODOR N; BREWSTER ME.1983; EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY; ISSN 0223-5234; FRA; DA. 1983; VOL. 18; NO 3; PP. 235-240; ABS. FRE/GER; BIBL. 23 REF.Article

DETERMINATION OF PENICILLINS AND CEPHALOSPORINS USING 3-BROMO-4,4-DIMETHYL-2-OXAZOLIDINONEKAMINSKIJ JJ; BODOR N.1979; INTERNATION. J. PHARMACEUT.; NLD; DA. 1979; VOL. 3; NO 2-3; PP. 151-156; BIBL. 5 REF.Article

FORMATION, STABILITY, AND PROTONATION OF DIHYDROPYRIDINES. A MINDO/3 STUDYBODOR N; PEARLMAN R.1978; J. AMER. CHEM. SOC.; USA; DA. 1978; VOL. 100; NO 16; PP. 4946-4953; BIBL. 11 REF.Article

IMPROVED DELIVERY THROUGH BIOLOGICAL MEMBRANES. VIII: DESIGN, SYNTHESIS AND IN VIVO TESTING OF TRUE PRODRUGS OF ASPIRINLOFTSSON T; KAMINSKI JJ; BODOR N et al.1981; J. PHARM. SCI.; ISSN 0022-3549; USA; DA. 1981; VOL. 70; NO 7; PP. 743-749; BIBL. 35 REF.Article

A STUDY OF THE INTERACTIONS BETWEEN THE DOUBLE BONDS IN UNSATURATED KETONESBODOR N; DEWAR MJS; MAKSIC ZB et al.1976; CROAT. CHEM. ACTA; YOUGOSL.; DA. 1976; VOL. 48; NO 1; PP. 9-15; ABS. SERBO-CROATE; BIBL. DISSEM.Article

IMPROVED DELIVERY THROUGH BIOLOGICAL MEMBRANES. VII: DERMAL DELIVERY OF CROMOGLYCIC ACID (CROMOLYN) VIA ITS PRODRUGSBODOR N; ZUPAN J; SELK S et al.1980; INT. J. PHARM.; ISSN 0378-5173; NLD; DA. 1980; VOL. 7; NO 1; PP. 63-75; BIBL. 15 REF.Article

RESOLUTION OF CHIRAL PHOSPHAMIDESBODOR N; KNUTSON K; SATO T et al.1980; J. AMER. CHEM. SOC.; USA; DA. 1980; VOL. 102; NO 11; PP. 3969-3971; BIBL. 14 REF.Article

N-HALO DERIVATIVES. IV. SYNTHESIS OF LOW CHLORINE POTENTIAL SOFT N-CHLORAMINE SYSTEMS.KAMINSKI JJ; BODOR N; HIGUCHI T et al.1976; J. PHARM. SCI.; U.S.A.; DA. 1976; VOL. 65; NO 12; PP. 1733-1737; BIBL. 13 REF.Article